Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis
Open Access
- 15 April 2003
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 88 (8) , 1217-1222
- https://doi.org/10.1038/sj.bjc.6600865
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.2002
- Head and Neck CancerNew England Journal of Medicine, 2002
- Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagusGastroenterology, 2002
- Many actions of cyclooxygenase‐2 in cellular dynamics and in cancerJournal of Cellular Physiology, 2002
- Screening for oesophageal neoplasia in patients with head and neck cancerBritish Journal of Cancer, 2002
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2Journal of Biological Chemistry, 1996
- Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect.Proceedings of the National Academy of Sciences, 1996
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell, 1995
- Differential Activation of Peroxisome Proliferator-activated Receptors by EicosanoidsJournal of Biological Chemistry, 1995